TABLE 2.

Baseline values of sputum inflammatory markers measured in early and late induced-sputum samples

	HFA-BDP group		DPI-BUD group
	Early sputum	Late sputum	Early sputum	Late sputum
Eosinophils (%)	8.3 ± 1.9	6.3 ± 1.5	9.7 ± 2.6	7.7 ± 2.2
Neutrophils (%)	27.4 ± 5.9	28.3 ± 6.5	34.8 ± 4.5	31.7 ± 4.8
Lymphocytes (%)	1.2 ± 0.5	1.4 ± 0.7	0.5 ± 0.2	0.6 ± 0.2
Macrophages (%)	54.7 ± 5.5	51.4 ± 9.2	39.5 ± 4.8	43.3 ± 5.7
IL-4-positive cells (%)	7.4 ± 0.5	6.7 ± 0.6	7.0 ± 1.1	4.5 ± 0.4
IL-5-positive cells (%)	5.7 ± 0.6	5.6 ± 0.8	8.2 ± 1.3	7.5 ± 1.4

DPI-BUD Budesonide in a dry powder inhaler; HFA-BDP Hydrofluoroalkane formulation of beclomethasone dipropionate; IL Interleukin